| |
| Financial Statements |
| for the Period from |
| CONTENTS | PAGE |
| Company Information | 2 |
| Statement of Financial Position | 3 |
| Notes to the Accounts | 4 |
| Company Details | |
| Company Number | 15512183 |
| Registered Office | WOODCHURCH ROAD PHARMACY 379 WOODCHURCH ROAD |
| PRENTON | |
| BIRKENHEAD | |
| WIRRAL | |
| CH42 8PE | |
| Directors | |
| Directors who held office during the period were: | |
| | |
| | |
| Notes | 2026 | 2025 | ||
| £ | £ | |||
| Fixed Assets | ||||
| Investment Properties | 5 | |||
| Investments | 6 | |||
| Current Assets | ||||
| Debtors due | 7 | |||
| Cash at bank and in hand | ||||
| Creditors | ||||
| Amount falling due within one year | 8 | ( | ( | |
| Net Current Assets | ( | ( | ||
| Total Assets less current liabilities | ||||
| Creditors due after more than one year | 9 | ( | ||
| Net Assets | ||||
| Capital and Reserves | ||||
| Called up Share Capital | ||||
| Retained earnings at end of year | ||||
| Shareholder funds | ||||
| |
| |
| |
| |
| |
| |
| |
| Approved by the Board on |
| Mark Joynson |
| Company Registration No. |
| 1. Statutory Information |
| MOSEY JOYNSON GROUP LTD is a private company, limited by shares, registered in England and Wales, registration number 15512183. |
| 2. Accounting Policies |
| Basis of preparing the Financial Statements |
| |
| Presentation Currency |
| |
| Turnover |
| |
| Current Tax |
| |
| Deferred Tax |
| |
| 3. Employees | |
| Average number of employees, including directors, during the year was as follows: | |
| 2026 | |
| 2025 | |
| 4. Principal Activity | |
| | |
| 5. Investment Properties | ||||
| 2026 | 2025 | |||
| £ | £ | |||
| Valuation at 01/03/2025 | ||||
| Additions | ||||
| Disposals | ||||
| Transfered (to)/from tangible fixed assets | ||||
| Fair Value adjustments | ||||
| Valuation at 28/02/2026 | ||||
| 6. Investments | |||||||
| Investments in Subsidiaries | Other Investments - Listed | Other Investments -Unlisted | Total | ||||
| £ | £ | £ | £ | ||||
| Valuation at 01/03/2025 | - | ||||||
| Additions | - | - | - | - | |||
| Disposals | - | - | - | - | |||
| Adjustments | - | - | - | - | |||
| Valuation at 28/02/2026 | - | ||||||
| 7. Debtors | ||||
| 2026 | 2025 | |||
| £ | £ | |||
| Trade debtors | ||||
| Other debtors | ||||
| Prepayment and accrued income | ||||
| Debtors Notes |
| |
| 8. Creditors: amount falling due within one year | ||||
| 2026 | 2025 | |||
| £ | £ | |||
| Bank Loans and other overdrafts | ||||
| Trade Creditors | ||||
| Corporation Tax | ||||
| Other tax and social security | ||||
| Other Creditors | ||||
| Accruals and deferred income | ||||
| Creditors Due within one year |
| |
| 9. Creditors: amount falling due after one year | ||||
| 2026 | 2025 | |||
| £ | £ | |||
| Bank Loans and overdrafts | ||||
| Creditors Due after one year |
| Bank loans of £1,037,595 (2025: £nil) are repayable by monthly instalments, with the outstanding balance repayable in full at the end of a five-year term. Bank loans are stated net of unamortised arrangement costs, which are charged to profit or loss over the term of the loan.Total bank loans of £1,088,845 (2025: £746,098) are secured by a legal charge over the company's freehold property and by a debenture containing fixed and floating charges over all of the property and undertaking of the company. The bank loan outstanding at 28 February 2025 was secured by charges over the same property and was repaid in full during the year on refinancing. |
| 10. Guarantees and Financial Commitments | ||||
| |
| 11. Transition to FRS102 |
| |
| 12. Post Balance Sheet Events |
| After the year end the company entered into a further secured term loan facility, repayable over five years, to fund the expansion of the group.Following improvement works carried out after the year end, the company's investment property was independently valued at an amount in excess of its carrying value.Neither event is reflected in these accounts. |
| 13. Additional Notes |
| Investment propertyInvestment property is measured at fair value at each reporting date, with changes in fair value recognised in profit or loss. No depreciation is provided.The investment property was valued by the directors at 28 February 2026 with reference to its acquisition cost and current market conditions. The valuation was not carried out by an independent valuer. The historical cost of the property is £130,000 (2025: £130,000). The property is let to the company's subsidiary under a lease on commercial terms.Subsidiary undertakingInvestments in subsidiaries are measured at cost less any accumulated impairment. The company owns 100% of the ordinary share capital of D Butler Healthcare Ltd, a company incorporated in Northern Ireland, whose registered office is 63 Prehen Park, Waterside, Londonderry, BT47 2PA.Related party transactionsThe company has taken advantage of the exemption in FRS 102 Section 33 not to disclose transactions with its wholly owned subsidiary. The company is controlled by its directors. |